{"schema_version":"secwatch.filing_event.v1","accession":"0001174947-22-001093","form_type":"8-K","ticker":"CNMD","cik":"0000816956","company_name":"CONMED Corp","filed_at":"2022-10-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.647927+00:00","generated_at":"2026-06-23T01:02:46.774181+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CONMED Q3 sales $275.1M (+10.6% YoY); adjusted EPS $0.77 misses prior year; narrows 2022 guidance","bullets":["Sales $275.1M +10.6% as reported, +12.1% constant currency; domestic +14.2%, international +6.2% as reported.","GAAP diluted EPS $1.48 (vs $0.47 Q3 2021); adjusted diluted EPS $0.77 (vs $0.80) down 3.8%.","Full-year 2022 revenue guidance narrowed to $1.1B-$1.115B; adjusted EPS guidance lowered to $3.21-$3.28 from $3.25-$3.45.","Closed Biorez acquisition on Aug 9, 2022; integrates with recent In2Bones acquisition.","Orthopedic Surgery sales $118.6M +12.2% as reported; General Surgery $156.5M +9.4%. Single-use +15.1%, capital -8.5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001174947-22-001093","json":"https://secwatch.observer/filing/0001174947-22-001093.json","markdown":"https://secwatch.observer/filing/0001174947-22-001093.md","text":"https://secwatch.observer/filing/0001174947-22-001093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/816956/000117494722001093/0001174947-22-001093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/816956/000117494722001093/form8k-28878_cnmd.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T01:02:46.774181+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}